Related Experiment Video
Updated: Aug 27, 2025

A Coregistered Ultrasound and Photoacoustic Imaging Protocol for the Transvaginal Imaging of Ovarian Lesions
Published on: March 3, 2023
Uterine adenomyotic cyst with markedly elevated serum CA19‑9 and CA125 levels: A case report
Lihua Zheng1, Li Shan1, Fengfeng Cai2
1Department of Gynecology and Obstetrics, Northwest Women's and Children's Hospital, Xi'an, Shaanxi 710012, P.R. China.
Insights
This study details a rare case of a large adenomyotic cyst presenting with significantly elevated cancer antigen 19-9 (CA19-9) and CA125 tumor markers. Despite high levels, the lesion was benign, highlighting unusual marker elevation in non-malignant conditions.
Area of Science:
- Gynecologic Pathology
- Diagnostic Imaging
- Clinical Biochemistry
Background:
- Adenomyotic cysts are typically small (<5 mm) and contain hemorrhagic material.
- Elevated serum tumor markers like CA125 are sometimes associated with large adenomyotic cysts.
- Simultaneous elevation of CA19-9 and CA125 in adenomyotic cysts is uncommon.
Abstract:
Adenomyotic cysts are small cysts with a diameter of <5 mm, usually containing hemorrhagic material. The present study reported on a patient with a large adenomyotic cyst with abnormally high serum levels of CA19-9 (>1,000 U/ml) and CA125 (642 U/ml) and a complaint of pelvic pain. MRI scans were critical in diagnosing the case. Adhering to the principle of tumor-free implantation, a laparotomy was performed. After the operation, six weeks were required to normalize the serum level of CA19-9 and four weeks for CA125. Elevated tumor markers are frequently observed in malignancies, but the outcome reported in the present case was a benign lesion and the prognosis was favorable. In the present case, it was unusual that CA19-9 was elevated in addition to CA125, as it is commonly reported that only CA125 is elevated in cases of large adenomyotic cyst.
More Related Videos
Related Concept Videos
Disorders of the Female Reproductive System
Ovarian Cycle
Oogenesis

